Local clinical care
A GP, obesity specialist or endocrinologist can assess medical risk, local medicine availability and the need for tests or specialist referral.
Modern obesity treatment in Europe
Obesity treatment: BMI, medicines and weight-loss injections
Obesity is a chronic disease that can be treated. Explore lifestyle support, prescription medicines such as GLP-1 therapies, and routes to professional assessment across Europe.
Start consultationPrescription may be issued after medical assessmentExplore treatment optionsCalculate BMI
A doctor assesses suitability and, if treatment is appropriate, may issue a prescription. You receive 10% off care with the partner service.
✓ EU regulatory sources✓ No medicine sales✓ Clinician-led treatment
01 · Orientation
Calculate your BMI
Enter height and weight for an adult BMI estimate. BMI is only one part of a clinical assessment.
BMI is not a diagnosisIt does not capture age, body composition, fat distribution or your full medical situation.
—BMI
02 · Treatment pathway
Obesity treatment is more than one intervention
Lifestyle measures remain important, while prescription medication or specialist care may be appropriate for some people after clinical assessment.
- 01Foundation
Lifestyle support
Nutrition, physical activity, sleep and sustainable behavioural changes.
- 02Additional option
Obesity medicines
Prescription treatment may include GLP-1 and related medicines when clinically appropriate.
- 03Specialist care
When more support is needed
Specialist obesity services can combine medical, nutritional, psychological and surgical options.
03 · Popular searches
Explore the topics people look for most
Detailed pages answer high-intent questions without turning medicine names into sales claims.
Weight-loss injections
GLP-1, Wegovy, Mounjaro and how injectable obesity treatment works.
Mounjaro vs Wegovy
Compare tirzepatide and semaglutide.
Mounjaro price
Why cost varies across Europe and how to verify it.
Wegovy price
Local pricing, reimbursement and safe sourcing.
Wegovy tablets
2026 update: oral semaglutide is now part of the EU Wegovy authorisation.
GLP-1 explained
Understand the mechanism and key medicines.
Online obesity treatment
What a remote clinical assessment may involve.
affiliate option
Online medical consultation
Remote assessment can be convenient for some people. A prescription is not automatic or guaranteed. The clinician decides whether treatment is appropriate and safe.
Start consultationPrescription may be issued after medical assessment*Affiliate link. You receive a 10% discount on care. WeightGuide.eu receives a 10% commission.04 · Common questions
Frequently asked questions about obesity medicines in Europe
Who may be eligible for prescription obesity medicines?
For some EU-authorised medicines, adult weight-management treatment is indicated from a BMI of 30 kg/m², or from 27 to under 30 kg/m² when at least one weight-related comorbidity is present. A clinician still needs to assess individual suitability.
What is the difference between Wegovy and Ozempic?
Both contain semaglutide, but their authorised uses differ. Wegovy is authorised for weight management in defined groups, while Ozempic is authorised in the EU for insufficiently controlled type 2 diabetes.
What is Mounjaro?
Mounjaro contains tirzepatide, which acts on GIP and GLP-1 receptors. It has EU indications for type 2 diabetes and for weight management in defined groups of adults.
Are Wegovy tablets available in the EU?
EMA product information updated in August 2026 includes Wegovy given by injection or as oral tablets for adults. Actual market availability, price and reimbursement can still differ by country.
Does an online consultation guarantee a prescription?
No. A clinician may decide that a medicine is not appropriate, that more information is needed or that in-person assessment is preferable. Prescribing also depends on local rules.